Persistent Helicobacter pylori infection after a course of antimicrobial therapy-what's next?
Saad
Richard J
RJ
Division of Gastroenterology, Department of Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.
Chey
William D
WD
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004386:Duodenum / Q000473:pathology; D005260:Female; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D016879:Salvage Therapy / Q000379:methods*; D013270:Stomach / Q000382:microbiology / Q000473:pathology
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors